🎥✨ Martes de Divulgación Científica - 08 de abril 2025 - Ensayos clínicos

🎥✨ Martes de Divulgación Científica - 08 de abril 2025 - Ensayos clínicos

🎙 GESTION DEL CONOCIMIENTO INSNSB 👥 767 📅 January 23, 2026 ⏱ 64 min 👁 21 📄 expert opinion 🧭 2026-08-13
Available in: English (current) Français

Keywords

ensayos clínicospediatríaconsentimiento informadofasesregulación

Summary

The video is a scientific dissemination session on clinical trials in pediatrics, presented by Dr. Teobaldo Herrera Acuña, a pediatrician with extensive experience in clinical research. He begins by defining clinical trials as research studies in humans to evaluate the safety and efficacy of new interventions. He outlines the roles of sponsors, investigators, and contract research organizations, and describes the process from feasibility assessment to regulatory approval. He emphasizes the importance of the protocol, which details the study design, eligibility criteria, and procedures. He explains the phases of clinical trials (0-IV), highlighting their objectives and participant numbers. He discusses regulatory bodies such as the FDA, EMA, and in Peru, the Instituto Nacional de Salud (INS), and mentions the national regulation from 2017. He stresses the ethical considerations in pediatric research, including the need for informed consent from both parents and assent from children over 8 years old. He notes that only 2% of clinical trials in Peru are pediatric, underscoring the need for more research in this population. He also touches on practical aspects like participant retention, blinding, and data confidentiality. The talk concludes with reflections on the importance of pediatric clinical trials for ensuring appropriate dosing and safety in children.

201 words

Critical Evaluation

Value of the Information & Strength of the Argument

The video provides valuable practical insights into the conduct of pediatric clinical trials, drawing on the speaker’s extensive experience. The argumentation is coherent and logically structured, moving from definitions to regulatory frameworks and ethical considerations. The speaker effectively communicates the complexities of clinical research, such as the lengthy approval process and the need for meticulous documentation. However, the talk is largely anecdotal and lacks rigorous scientific depth, with no specific data or references to support claims. The emphasis on ethical principles and the importance of pediatric research is commendable, but the presentation would benefit from more concrete examples and evidence.

109 words

Title / Content Match

The title accurately reflects the content, which is a scientific dissemination session on clinical trials in pediatrics.

Quality & Reliability

7/10

The speaker is a pediatrician with over 15 years of experience as principal investigator in clinical trials, providing practical insights. However, the talk is largely anecdotal and lacks detailed citations or references to specific studies or regulations beyond general mentions.

Key Moments

Cited Sources

  • Instituto Nacional de Salud (INS) - Registro de Ensayos Clínicos (REPEC) — Mentioned as the Peruvian regulatory body and the registry for clinical trials.
  • Reglamento de Ensayos Clínicos (Peru, 2017) — Referenced as the current regulation governing clinical trials in Peru.

Concurring Sources

  • FDA Pediatric Drug Development — Supports the need for pediatric-specific research and regulatory frameworks.

Contribution & Novelties

The video offers a practical, experience-based overview of pediatric clinical trials, highlighting the regulatory and ethical complexities specific to this population. It emphasizes the low percentage of pediatric trials and the need for more research. The speaker’s insights into informed consent and assent processes are valuable for practitioners.

Pour aller plus loin :

104 words

Radar Profile

The radar profile shows a balanced but moderate performance across all dimensions, with slightly higher scores in quantity of information and technical level, reflecting the speaker's experience. The lower scores in quality and reliability indicate a lack of rigorous citations and scientific depth.

Reliability 6/10